Drug Companies to Proceed with $26 Billion Deal to Address the Opioid Crisis

0
296

“I’m asking our local government officials to support this effort to help people in our state who are dealing with substance use disorders by signing on to this historic agreement. Now is the time to step up for your constituents,” said AG Stein.

Key details of the $26 billion opioid settlement

AmerisourceBergen, Cardinal Health, and McKesson will pay up to $21 billion over 18 years. Johnson & Johnson will pay up to $5 billion over nine years, $3.7 billion to be paid during the first three years.

A substantial portion of the settlement will be used to provide treatment for people suffering from opioid addiction and to stop the opioid crisis.

Signup for the USA Herald exclusive Newsletter

The settlement also includes injunctive relief to prevent drug companies from reigniting another opioid crisis in the future.

AmerisourceBergen, Cardinal Health, and McKesson are required to use data-driven systems to detect suspicious opioid orders from customer pharmacies for ten years.

The three major drug distributors are also required to report and prohibit the shipping of suspicious opioid orders and prohibit sales staff from influencing decisions related to identifying suspicious opioid orders.